AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
PHASE-II TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-4 IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: WHITEHEAD RP UNGER JM GOODWIN JW WALKER MJ THOMPSON JA FLAHERTY LE SONDAK VK
Citation: Rp. Whitehead et al., PHASE-II TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-4 IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of immunotherapy, 21(6), 1998, pp. 440-446
COMPLETE SPONTANEOUS REGRESSION OF PULMONARY METASTATIC MELANOMA
Authors: WANG TS LOWE L SMITH JW FRANCIS IR SONDAK VK DWORZANIAN L FINKELSTEIN S SLINGLUFF CL JOHNSON TM
Citation: Ts. Wang et al., COMPLETE SPONTANEOUS REGRESSION OF PULMONARY METASTATIC MELANOMA, Dermatologic surgery, 24(8), 1998, pp. 915-919
PREOPERATIVE IDOXURIDINE AND RADIATION FOR LARGE SOFT-TISSUE SARCOMAS, CLINICAL-RESULTS WITH 5-YEAR FOLLOW-UP
Authors: SONDAK VK ROBERTSON JM SUSSMAN JJ SARAN PA CHANG AE LAWRENCE TS
Citation: Vk. Sondak et al., PREOPERATIVE IDOXURIDINE AND RADIATION FOR LARGE SOFT-TISSUE SARCOMAS, CLINICAL-RESULTS WITH 5-YEAR FOLLOW-UP, Annals of surgical oncology, 5(2), 1998, pp. 106-112
IMMUNOLYMPHOSCINTIGRAPHY IN BREAST-CANCER - EVALUATION USING I-131-LABELED MONOCLONAL-ANTIBODY B72.3
Authors: FIG LM BROWN RS VONMOLL L APPELMAN HD STEVENS R HARNESS J AUGUST D SONDAK VK CHANG AE ZASADNY KR FISHER SJ JOHNSON JW WICHA MS COLCHER D LICHTER AS WAHL RL
Citation: Lm. Fig et al., IMMUNOLYMPHOSCINTIGRAPHY IN BREAST-CANCER - EVALUATION USING I-131-LABELED MONOCLONAL-ANTIBODY B72.3, Nuclear medicine and biology, 25(3), 1998, pp. 251-260
PHASE-II STUDY OF CARMUSTINE, DACARBAZINE, CISPLATIN, AND TAMOXIFEN IN ADVANCED MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: MARGOLIN KA LIU PY FLAHERTY LE SOSMAN JA WALKER MJ SMITH JW FLETCHER WS WEISS GR UNGER JM SONDAK VK
Citation: Ka. Margolin et al., PHASE-II STUDY OF CARMUSTINE, DACARBAZINE, CISPLATIN, AND TAMOXIFEN IN ADVANCED MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 16(2), 1998, pp. 664-669
ADVANCES IN MELANOMA THERAPY
Authors: JOHNSON TM YAHANDA AM CHANG AE FADER DJ SONDAK VK
Citation: Tm. Johnson et al., ADVANCES IN MELANOMA THERAPY, Journal of the American Academy of Dermatology, 38(5), 1998, pp. 731-741
ECONOMIC-IMPLICATIONS OF HEPATIC ARTERIAL INFUSION CHEMOTHERAPY IN TREATMENT OF NONRESECTABLE COLORECTAL LIVER METASTASES
Authors: DURANDZALESKI I ROCHE B BUYSE M CARLSON R OCONNELL MJ ROUGIER P CHANG AE SONDAK VK KEMENY MM ALLENMERSH TG FAGNIEZ PL LEBOURGEOIS JP PIEDBOIS P
Citation: I. Durandzaleski et al., ECONOMIC-IMPLICATIONS OF HEPATIC ARTERIAL INFUSION CHEMOTHERAPY IN TREATMENT OF NONRESECTABLE COLORECTAL LIVER METASTASES, Journal of the National Cancer Institute, 89(11), 1997, pp. 790-795
COMPUTED-TOMOGRAPHY IN STAGING OF PATIENTS WITH MELANOMA METASTATIC TO THE REGIONAL NODES
Authors: JOHNSON TM FADER DJ CHANG AE YAHANDA A SMITH JW HAMLET KR SONDAK VK
Citation: Tm. Johnson et al., COMPUTED-TOMOGRAPHY IN STAGING OF PATIENTS WITH MELANOMA METASTATIC TO THE REGIONAL NODES, Annals of surgical oncology, 4(5), 1997, pp. 396-402
TUMOR-INDUCED SUPPRESSION OF ANTITUMOR REACTIVITY AND DEPRESSION OF TCR-ZETA EXPRESSION IN TUMOR-DRAINING LYMPH-NODE LYMPHOCYTES - POSSIBLERELATIONSHIP TO THE TH2 PATHWAY
Authors: FU EJ ARCA MJ HAIN JM KRINOCK R RADO J CAMERON MJ CHANG AE SONDAK VK
Citation: Ej. Fu et al., TUMOR-INDUCED SUPPRESSION OF ANTITUMOR REACTIVITY AND DEPRESSION OF TCR-ZETA EXPRESSION IN TUMOR-DRAINING LYMPH-NODE LYMPHOCYTES - POSSIBLERELATIONSHIP TO THE TH2 PATHWAY, Journal of immunotherapy with emphasis on tumor immunology, 20(2), 1997, pp. 111-122
PHASE I II TRIAL OF THE IL-2 DNA/DMRIE/DOPE LIPID COMPLEX AS AN IMMUNOTHERAPEUTIC AGENT BY DIRECT GENE-TRANSFER IN PATIENTS WITH ADVANCED MELANOMA, RENAL-CELL CARCINOMA, AND SARCOMA/
Authors: RUBIN J GALANIS E BURCH P HERSH EM SPIER C AKPORIAYE E GONZALEZ R RINEHART JJ SOBOL RE SONDAK VK STAHL SM
Citation: J. Rubin et al., PHASE I II TRIAL OF THE IL-2 DNA/DMRIE/DOPE LIPID COMPLEX AS AN IMMUNOTHERAPEUTIC AGENT BY DIRECT GENE-TRANSFER IN PATIENTS WITH ADVANCED MELANOMA, RENAL-CELL CARCINOMA, AND SARCOMA/, Cancer gene therapy, 4(6), 1997, pp. 125-125
ADOPTIVE IMMUNOTHERAPY WITH VACCINE-PRIMED LYMPH-NODE CELLS SECONDARILY ACTIVATED WITH ANTI-CD3 AND INTERLEUKIN-2
Authors: CHANG AE ARUGA A CAMERON MJ SONDAK VK NORMOLLE DP FOX BA SHU SY
Citation: Ae. Chang et al., ADOPTIVE IMMUNOTHERAPY WITH VACCINE-PRIMED LYMPH-NODE CELLS SECONDARILY ACTIVATED WITH ANTI-CD3 AND INTERLEUKIN-2, Journal of clinical oncology, 15(2), 1997, pp. 796-807
COMPARISON OF PATIENT CHARACTERISTICS AND OUTCOME BETWEEN A SINGLE-INSTITUTION PHASE-II TRIAL AND A COOPERATIVE-GROUP PHASE-II TRIAL WITH IDENTICAL ELIGIBILITY IN METASTATIC MELANOMA
Authors: FLAHERTY LE LIU PY UNGER J SONDAK VK
Citation: Le. Flaherty et al., COMPARISON OF PATIENT CHARACTERISTICS AND OUTCOME BETWEEN A SINGLE-INSTITUTION PHASE-II TRIAL AND A COOPERATIVE-GROUP PHASE-II TRIAL WITH IDENTICAL ELIGIBILITY IN METASTATIC MELANOMA, American journal of clinical oncology, 20(6), 1997, pp. 600-604
MOHS MICROGRAPHIC SURGERY FOR THE TREATMENT OF DERMATOFIBROSARCOMA PROTUBERANS - RESULTS OF A MULTIINSTITUTIONAL SERIES WITH AN ANALYSIS OFTHE EXTENT OF MICROSCOPIC SPREAD
Authors: RATNER D THOMAS CO JOHNSON TM SONDAK VK HAMILTON TA NELSON BR SWANSON NA GARCIA C CLARK RE GRANDE DJ
Citation: D. Ratner et al., MOHS MICROGRAPHIC SURGERY FOR THE TREATMENT OF DERMATOFIBROSARCOMA PROTUBERANS - RESULTS OF A MULTIINSTITUTIONAL SERIES WITH AN ANALYSIS OFTHE EXTENT OF MICROSCOPIC SPREAD, Journal of the American Academy of Dermatology, 37(4), 1997, pp. 600-613
THE UTILITY OF FINE-NEEDLE ASPIRATION IN THE DIAGNOSIS OF MELANOMA METASTATIC TO LYMPH-NODES
Authors: BASLER GC FADER DJ YAHANDA A SONDAK VK JOHNSON TM
Citation: Gc. Basler et al., THE UTILITY OF FINE-NEEDLE ASPIRATION IN THE DIAGNOSIS OF MELANOMA METASTATIC TO LYMPH-NODES, Journal of the American Academy of Dermatology, 36(3), 1997, pp. 403-408
TYPE-1 VERSUS TYPE-2 CYTOKINE RELEASE BY V-BETA T-CELL SUBPOPULATIONSDETERMINES IN-VIVO ANTITUMOR REACTIVITY - IL-10 MEDIATES A SUPPRESSIVE ROLE
Authors: ARUGA A ARUGA E TANIGAWA K BISHOP DK SONDAK VK CHANG AE
Citation: A. Aruga et al., TYPE-1 VERSUS TYPE-2 CYTOKINE RELEASE BY V-BETA T-CELL SUBPOPULATIONSDETERMINES IN-VIVO ANTITUMOR REACTIVITY - IL-10 MEDIATES A SUPPRESSIVE ROLE, The Journal of immunology, 159(2), 1997, pp. 664-673
SURGICAL THERAPY OF PRIMARY CUTANEOUS MELANOMA
Authors: GERAGHTY PJ JOHNSON TM SONDAK VK CHANG AE
Citation: Pj. Geraghty et al., SURGICAL THERAPY OF PRIMARY CUTANEOUS MELANOMA, Seminars in surgical oncology, 12(6), 1996, pp. 386-393
RANDOMIZED TRIAL OF ADJUVANT HUMAN INTERFERON-GAMMA VERSUS OBSERVATION IN HIGH-RISK CUTANEOUS MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY -RESPONSE
Authors: SONDAK VK KOPECKY KJ MEYSKENS FL
Citation: Vk. Sondak et al., RANDOMIZED TRIAL OF ADJUVANT HUMAN INTERFERON-GAMMA VERSUS OBSERVATION IN HIGH-RISK CUTANEOUS MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY -RESPONSE, Journal of the National Cancer Institute, 88(13), 1996, pp. 927-927
MULTIINSTITUTIONAL MELANOMA VACCINE TRIAL
Authors: SONDAK VK
Citation: Vk. Sondak, MULTIINSTITUTIONAL MELANOMA VACCINE TRIAL, Annals of surgical oncology, 3(6), 1996, pp. 588-589
ADOPTIVE IMMUNOTHERAPY OF CANCER WITH ACTIVATED LYMPH-NODE CELLS PRIMED IN-VIVO WITH AUTOLOGOUS TUMOR-CELLS TRANSDUCED WITH THE GM-CSF GENE
Authors: CHANG AE SONDAK VK BISHOP DK NICKOLOFF BJ MULLIGAN RC MULE JJ
Citation: Ae. Chang et al., ADOPTIVE IMMUNOTHERAPY OF CANCER WITH ACTIVATED LYMPH-NODE CELLS PRIMED IN-VIVO WITH AUTOLOGOUS TUMOR-CELLS TRANSDUCED WITH THE GM-CSF GENE, Human gene therapy, 7(6), 1996, pp. 773-792
THE ADDITION OF TAMOXIFEN TO DACARBAZINE AND CISPLATIN IN METASTATIC MALIGNANT-MELANOMA - A PHASE-II TRIAL OF THE SOUTHWEST ONCOLOGY GROUP (SWOG-8921)
Authors: FLAHERTY LE LIU PY MITCHELL MS FLETCHER WS WALKER MJ GOODWIN JW STEPHENS RL SONDAK VK
Citation: Le. Flaherty et al., THE ADDITION OF TAMOXIFEN TO DACARBAZINE AND CISPLATIN IN METASTATIC MALIGNANT-MELANOMA - A PHASE-II TRIAL OF THE SOUTHWEST ONCOLOGY GROUP (SWOG-8921), American journal of clinical oncology, 19(2), 1996, pp. 108-113
A CENTIMETER HERE, A CENTIMETER THERE - REPLY
Authors: SONDAK VK JOHNSON TM
Citation: Vk. Sondak et Tm. Johnson, A CENTIMETER HERE, A CENTIMETER THERE - REPLY, Journal of the American Academy of Dermatology, 35(2), 1996, pp. 279-280
A CENTIMETER THERE, A CENTIMETER THERE - DOES IT MATTER - REPLY
Authors: SONDAK VK JOHNSON TM
Citation: Vk. Sondak et Tm. Johnson, A CENTIMETER THERE, A CENTIMETER THERE - DOES IT MATTER - REPLY, Journal of the American Academy of Dermatology, 35(2), 1996, pp. 281-282
RANDOMIZED TRIAL OF ADJUVANT HUMAN INTERFERON-GAMMA VERSUS OBSERVATION IN HIGH-RISK CUTANEOUS MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: MEYSKENS FL KOPECKY KJ TAYLOR CW NOYES RD TUTHILL RJ HERSH EM FEUN LG DOROSHOW JH FLAHERTY LE SONDAK VK
Citation: Fl. Meyskens et al., RANDOMIZED TRIAL OF ADJUVANT HUMAN INTERFERON-GAMMA VERSUS OBSERVATION IN HIGH-RISK CUTANEOUS MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of the National Cancer Institute, 87(22), 1995, pp. 1710-1713
A PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN THE TREATMENT OF METASTATIC COLORECTAL-CARCINOMA
Authors: CHANG AE CAMERON MJ SONDAK VK GEIGER JD VANDERWOUDE DL
Citation: Ae. Chang et al., A PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN THE TREATMENT OF METASTATIC COLORECTAL-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 253-262
PREOPERATIVE RADIATION-THERAPY AND IODODEOXYURIDINE FOR LARGE RETROPERITONEAL SARCOMAS
Authors: ROBERTSON JM SONDAK VK WEISS SA SUSSMAN JJ CHANG AE LAWRENCE TS
Citation: Jm. Robertson et al., PREOPERATIVE RADIATION-THERAPY AND IODODEOXYURIDINE FOR LARGE RETROPERITONEAL SARCOMAS, International journal of radiation oncology, biology, physics, 31(1), 1995, pp. 87-92
Risultati: 1-25 | 26-39